Showing results (1-10 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|December 1, 1992
Evaluation of combinations of antineoplastic ether phospholipids and chemotherapeutic drugsP Principe, H Coulomb, C Broquet, et al.Anti-Cancer Drugs|December 1, 1992
Immunomodulatory activity of two new aza alkyl phospholipid antineoplastic drugsB Pignol, S Chaumeron, H Coulomb, et al.Anti-Cancer Drugs|December 1, 1992
A possible modulatory influence of melatonin on representative phase I and II drug metabolizing enzymes in 9,10-dimethyl-1,2-benzanthracene induced rat mammary tumorigenesisL Kothari, A SubramanianAnti-Cancer Drugs|December 1, 1992
Interferon-alpha and -gamma in combination with chemotherapeutic drugs: in vitro sensitivity studies in four human mesothelioma cell linesA M Hand, K Husgafvel-Pursiainen, K Pelin, et al.Anti-Cancer Drugs|July 11, 2003
Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiformeBarbara Fazeny-Dörner, Mario Veitl, Catharina Wenzel, et al.Anti-Cancer Drugs|July 11, 2003
Cisplatin-induced encephalopathy and seizuresN Steeghs, F E de Jongh, P A E Sillevis Smitt, et al.Anti-Cancer Drugs|September 10, 2003
Modulation of drug and radiation resistance in small cell lung cancer cells by paclitaxelVicki L Locke, Ross A Davey, Mary W DaveyAnti-Cancer Drugs|June 15, 2022
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group studyÖzlem Özdemir, Baha Zengel, Yaşar Yildiz, et al.Anti-Cancer Drugs|October 1, 1990
Cisplatin stimulates the expression from the human immunodeficiency virus long terminal repeat sequences in human fibroblastsV Zoumpourlis, P Patsilinacos, A Kotsinas, et al.Anti-Cancer Drugs|December 1, 1990
Metal complexes of ruthenium: antineoplastic properties and perspectivesG Sava, S Pacor, F Bregant, et al.Pageof 464